HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma

Published:2025 Issue: Volume:36 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Mizoguchi Chiharu¹^ORCID,Nishikawa Tadaaki¹^ORCID,Yoshida Hiroshi²^ORCID,Yasuda Masanori³^ORCID,Kato Tomoyasu⁴^ORCID,Hasegawa Kosei⁵^ORCID,Yonemori Kan¹^ORCID

Affiliation:

1. Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

2. Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.

3. Department of Diagnostic Pathology, Saitama Medical University International Medical Center, Hidaka, Japan.

4. Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.

5. Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2025.36.e14

Reference30 articles.

1. Uterine carcinosarcoma: Immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets

2. Clinical features and outcomes of uterine and ovarian carcinosarcoma

3. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

4. Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma

5. Uterine carcinosarcoma: A review of the literature

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP